Blood Sugar Converter for Gestational Diabetes — Pregnancy Targets

What Blood Sugar Conversion Does

Blood glucose concentration can be reported in two different units depending on your location: milligrams per deciliter (mg/dL), which is standard in the United States, and millimoles per liter (mmol/L), which is used in most other countries including the UK, Canada, Australia, and Europe. This converter allows instant, accurate conversion between both units so that you can interpret lab results, glucose meter readings, or medical advice regardless of which unit is used.

The conversion is based on the molar mass of glucose — the weight of one mole of glucose molecules. Glucose has a molecular formula of C₆H₁₂O₆, giving it a molar mass of 180.182 g/mol. This fundamental chemical constant serves as the bridge between the mass-based unit (mg/dL) and the molar-based unit (mmol/L).

Conversion Formulas

Worked Example

Suppose your fasting blood glucose reading is 126 mg/dL. To convert to mmol/L: 126 ÷ 18.0182 = 7.0 mmol/L. This is the diagnostic threshold for diabetes according to the American Diabetes Association. Conversely, if a lab report shows a value of 5.6 mmol/L, convert to mg/dL: 5.6 × 18.0182 = 100.9 mg/dL ≈ 101 mg/dL. This is the upper end of the normal fasting range.

FAQ-Style Explanations

Why is the conversion factor 18.0182 and not exactly 18? The exact factor is derived from the molar mass of glucose (180.182 g/mol) divided by 10 (since 1 dL = 0.1 L). Many people use 18 as a quick approximation, but for clinical accuracy, especially at higher glucose levels, the full factor of 18.0182 should be used.

Which unit should I use? Use whichever unit your local healthcare system uses. In the US, all labs and glucose meters report in mg/dL. In most other countries, mmol/L is standard. The converter helps you move between the two seamlessly if you travel, consult international specialists, or read research from other countries.

Can I use this conversion for HbA1c? No. HbA1c (glycated hemoglobin) is a different measurement that represents average blood sugar over 2–3 months. It is reported as a percentage or in mmol/mol and requires a different conversion formula.

Known Limitations

• This converter provides accurate unit conversion but does not interpret your blood sugar levels — always consult a healthcare provider for medical interpretation.
• The conversion factor is based on the molecular weight of glucose in its standard form. Extremely rare laboratory variations in measurement techniques may introduce minor discrepancies at the thousandths place.
• Some glucose meters report in whole numbers only (e.g., 100 mg/dL rather than 100.0 mg/dL), which can introduce rounding differences of ±1 mg/dL or ±0.1 mmol/L.
• The reference ranges shown are general guidelines. Individual targets may vary based on age, diabetes type, pregnancy status, and other medical factors.

Reference Ranges

Why Pregnancy Requires Tighter Blood Sugar Control

During pregnancy, the placenta produces hormones — particularly human placental lactogen, cortisol, and progesterone — that deliberately induce insulin resistance in the mother to ensure adequate glucose delivery to the growing fetus. This physiological insulin resistance peaks in the second and third trimesters. In most pregnancies, the mother's pancreas compensates by producing more insulin, keeping blood sugar in a safe range. In approximately 6 to 9 percent of pregnancies, the pancreas cannot keep up, resulting in gestational diabetes mellitus (GDM). Even mildly elevated maternal blood sugar during pregnancy crosses the placenta and exposes the fetus to excess glucose, triggering fetal insulin hypersecretion, excessive fat deposition (macrosomia), and a range of acute and long-term complications. This is why pregnancy demands tighter blood sugar targets than non-pregnant adulthood — the fetus is far more vulnerable to glucose toxicity than the mother. Uncontrolled GDM is associated with a 3 to 5 times higher risk of macrosomia (birth weight above 4,000 grams), a 2 to 4 times higher risk of neonatal hypoglycemia, and a 30 to 40 percent increased risk of the child developing obesity and type 2 diabetes in later life.

Gestational Diabetes Blood Sugar Targets

Blood sugar targets for gestational diabetes are tighter than for non-pregnant adults. The American Diabetes Association and the International Association of Diabetes in Pregnancy Study Groups (IADPSG) recommend the following thresholds, which are lower than standard non-pregnant targets in every category. Fasting blood glucose should remain below 95 mg/dL (5.3 mmol/L) — compared to the non-pregnant normal of below 100 mg/dL. One-hour postprandial readings should stay below 140 mg/dL (7.8 mmol/L), and two-hour postprandial readings below 120 mg/dL (6.7 mmol/L) — compared to the non-pregnant normal of below 140 mg/dL at 2 hours. These tighter targets are based on large prospective studies linking each threshold to increased risk of adverse fetal outcomes. Some clinicians use even tighter targets (fasting below 90 mg/dL, 1-hour below 130 mg/dL) for women with particularly poor early control or a history of pregnancy complications, but the ADA/IADPSG thresholds are the standard starting point for most pregnancies with GDM.

Diagnosis Thresholds for Gestational Diabetes

Gestational diabetes is typically screened between 24 and 28 weeks of pregnancy using a 75-gram oral glucose tolerance test (OGTT). The IADPSG diagnostic thresholds, adopted by the ADA, diagnose GDM if any one value is met or exceeded: fasting 92 mg/dL (5.1 mmol/L) or higher, 1-hour 180 mg/dL (10.0 mmol/L) or higher, or 2-hour 153 mg/dL (8.5 mmol/L) or higher. Notably, these diagnostic thresholds are slightly lower than the treatment targets — the diagnosis is made at a lower threshold than the target to catch the condition early, before fetal complications develop. Women diagnosed with GDM at the standard screening visit should be considered as having already had elevated blood sugar for several weeks, since insulin resistance begins rising from the second trimester onward. Some high-risk women are screened earlier, at the first prenatal visit, using standard diabetes criteria (fasting 92 mg/dL / 5.1 mmol/L) to detect pre-existing undiagnosed type 2 diabetes, which requires different management.

mg/dL to mmol/L Conversion for Pregnancy Thresholds

Because pregnancy blood sugar thresholds use the same conversion factor as all blood glucose values (divide by 18.018 to convert mg/dL to mmol/L), the key values translate as follows: the GDM fasting target of 95 mg/dL equals 5.3 mmol/L; the 1-hour target of 140 mg/dL equals 7.8 mmol/L; and the 2-hour target of 120 mg/dL equals 6.7 mmol/L. For the diagnostic thresholds, 92 mg/dL equals 5.1 mmol/L, 180 mg/dL equals 10.0 mmol/L, and 153 mg/dL equals 8.5 mmol/L. If you are using a home glucometer that reports in mg/dL but your healthcare provider communicates targets in mmol/L (or vice versa), these conversions allow you to verify whether your readings meet your pregnancy-specific targets. Note that home glucometers have a margin of error of approximately 15 percent, so a single reading just outside the target range does not necessarily indicate a problem — the pattern across multiple readings is more informative.

Monitoring Frequency and Postpartum Follow-Up

Women with gestational diabetes are typically advised to self-monitor blood glucose at least 4 times daily — fasting and 1 or 2 hours after each main meal — using a home glucometer or, increasingly, a continuous glucose monitor (CGM). CGM devices have become a valuable tool in GDM management, providing real-time glucose data and trend information that helps women adjust meals and activity patterns to stay within target ranges. Most women with GDM (approximately 70 to 85 percent) can manage their blood sugar within target ranges through dietary modification and physical activity alone. The remaining 15 to 30 percent require medication — typically insulin or, increasingly, metformin — to achieve targets. After delivery, GDM resolves in most women within days to weeks, but it is a strong risk factor for future type 2 diabetes: women with a history of GDM have a 35 to 60 percent lifetime risk of developing type 2 diabetes within 10 to 20 years. A 75-gram OGTT should be performed at 6 to 12 weeks postpartum to confirm resolution, and annual diabetes screening is recommended thereafter.